ICH Reforms Will "Professionalize" Harmonization, PhRMA's Rep Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Shift in balance of power to regulators is "appropriate" and it's important that the public has trust in ICH, PhRMA Associate VP for Scientific and Regulatory Affairs Patrick Brady says; FDA proposes to contribute $500,000 per year to revised group.